PharmaLegacy Laboratories (Shanghai) Co., Ltdis a company with Non-Human Primates models latest reference price,Non-Human Primates modelsandLiver Fibrosis Model as the main business. We are committed to providing quality service of Humanized mouse model. PharmaLegacy Laboratories (Shanghai) Co., Ltdwas established in 10 years ago, As a company with a high sense of social responsibility, PharmaLegacyhas established a high reputation for superior quality and expertise in Osteoporosis Modelx2a38631nfield

   PharmaLegacy Laboratories (Shanghai) Co., Ltdis committed to the continuous improvement of theHuman Primates modelsservice, become a society, customers, shareholders and employees long-term trust of the company. Our Company adhering to pirit of for the sake of customers, and win-win with customers , and through PharmaLegacy staff continuous innovation and development to provide first-class Non-Human Primates models the measures,Non-Human Primates Capability manufacturers spot,Provide professional Non-Human Primates Capability,Efficient Non-Human Primates Capability for enterprises , is what we have been working for. Details:Non-human primates model (NHP) have closer phylogenetic relationship to human and the disease targets in NHP models share high cross-reactivity to the human target specific biological molecules which do not react with rodent counterpart. PharmaLegacy has therefore developed and validated serials of NHP platforms, covering Inflammation/ Autoimmune Diseases, Bone/Orthopedics, Respiratory Disease, as well as Pharmacokinetics Profiling Assay to test pharmacological effects and mechanisms of candidate drugs especially for therapeutic monoclonal antibodies. Experiments involving non-human primates (NHPs) include toxicity testing for medical and non-medical substances; studies of infectious disease, such as HIV and hepatitis; neurological studies; behavior and cognition; reproduction; genetics; and xenotransplantation. Around 65,000 NHPs are used every year in the United States, and around 7,000 across the European Union. Most of the NHPs used are one of three species of macaques, accounting for 79% of all primates used in research in the UK, and 63% of all federally funded research grants for projects using primates in the U.S. Lesser numbers of marmosets, tamarins, spider monkeys, owl monkeys, vervet monkeys, squirrel monkeys, and baboons are used in the UK and the US. Great Apes have not been used in the UK since a Government policy ban in 1998.

   With the rapid development of business simultaneously, PharmaLegacy always keeps the balance between external opportunities and internal management, attaching great importance to the training and shaping of core competitiveness. The company will take customer service value as the core competitiveness of enterprises. Adhering to spirit of enterprise:acting with integrity , pursuit of excellence, respect for the individual , PharmaLegacystrives to provide customers with Reliable Rheumatoid arthritis Model. More details in the PharmaLegacyofficial website: www.pharmalegacy.com